Skip to main content

Table 1 Characteristics of the patient's population according to the genotypes (N = 130)

From: Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?

Characteristics All Genotype 1 Genotype 3
  (N = 130) (N = 90) (N = 40)
Men n (%) 94 (72) 63 (70) 31 (77)
Race    
Caucasian n (%) 117 (90) 79 (87) 38 (95)
Age median, years 48 46.5 49
Alcohol abuse present, n (%) 22 (17) 15 (16) 7 (17)
Possible acquisition route n (%)    
IVDU 28 (21) 15 (16) 13 (32)
Parenteral 44 (33) 33 (36) 11 (27)
Parenteral and IVDU 5 (4) 3 (3) 2 (5)
Unknown 53 (40) 39 (43) 14 (35)
Leukocytes (× 104 cells/L) 6.35 6.35 5.94
median [interval] [2.7; 19] [2.7; 19] [3.9; 13]
Neutrophilis (× 106 cells/L) 3.38 3.28 5.94
median [interval] [0.33; 9.44] [0.33; 7.8] [0.8; 9.44]
Hemoglobin (mg/dL) 15.3 15.5 13.5
median [interval] [2.7; 19] [2.7; 19] [3.9; 13]
Platelets (× 103/mm3) 194 184 200
median [interval] [80; 345] [83; 345] [80; 275]
q ALT* 1.85 1.85 2.1
median [interval] [0.7; 9.3] [0.7; 5.1] [0.9; 9.3]
  1. qALT* = U/NUL